CooperCompanies
Develops contact lenses, fertility services and women’s-health medical devices.
$71.17
After-hours close+0.01 (+0.01%)
At close$71.16(+0.28%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 118.04%Insiders 1.00%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 195.03M · Float 193.67M · 99.3% free float
Institutions13F, as of Jun 30, 2026
681 holders · 230.21M shares · 114 new positions · 372 increased · 236 reduced · 113 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.03M | 7.71% | −1.59M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 12.76M | 6.54% | +39.9K | Aug 13, 2026 |
| State Street Corp | 8.89M | 4.56% | +124.2K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 8.67M | 4.45% | −51.6K | Aug 13, 2026 |
| T. Rowe Price Investment Management, Inc. | 7.43M | 3.81% | −1.63M | Aug 14, 2026 |
| Browning West LP | 7.20M | 3.69% | +215.9K | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 5.58M | 2.86% | +185.8K | Aug 14, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 5.43M | 2.78% | −1.19M | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.40% | 16.67M | Nov 8, 2024 ↗ | |
| Vanguard Capital Management | 7.51% | 14.66M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Robert McCuin | officer: EVP, Chief Revenue Officer | 845.4K | 0.43% | Feb 27, 2026 |
| Robert S. Weiss | director | 550.5K | 0.28% | Apr 6, 2026 |
| Albert G. III White | director, officer: President & CEO | 245.1K | 0.13% | Jan 12, 2026 |
| Daniel G. McBride | officer: EVP & Chief Operating Officer | 67.3K | 0.03% | Jan 12, 2026 |
| Holly R. Sheffield | officer: President, CSI | 42.2K | 0.02% | Jan 12, 2026 |
| Colleen Jay | director | 39.9K | 0.02% | Apr 6, 2026 |
| William A. Kozy | director | 31.1K | 0.02% | Apr 3, 2025 |
| Brian G. Andrews | officer: EVP, CFO & Treasurer | 30.7K | 0.02% | Jan 12, 2026 |
| Gerard H. III Warner | officer: President, CooperVision, Inc. | 21.0K | 0.01% | Jan 12, 2026 |
| Teresa S. Madden | director | 15.7K | 0.01% | Apr 6, 2026 |
25 people have not refiled in the last 18 months (1.80M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 22, 2025 | Cynthia L. Lucchesedirector | Purchase | 1,784 | $84.06 | 9,445 |
| Dec 18, 2025 | Maria Rivasdirector | Purchase | 1,000 | $82.13 | 11,141 |
| Dec 17, 2025 | Lawrence Erik Kurziusdirector | Purchase | 2,000 | $82.50 | 7,777 |
| Dec 16, 2025 | Albert G. III Whitedirector, officer: President & CEO | Purchase | 10,000 | $80.80 | 236,151 |
| Dec 16, 2025 | Holly R. Sheffieldofficer: President, CSI | Purchase | 1,230 | $80.75 | 39,052 |
| Sep 29, 2025 | Lawrence Erik Kurziusdirector | Purchase | 2,000 | $68.39 | 5,777 |
| Sep 5, 2025 | Gerard H. III Warnerofficer: President, CooperVision, Inc. | Purchase | 1,450 | $69.23 | 18,319 |
| Sep 5, 2025 | Albert G. III Whitedirector, officer: President & CEO | Purchase | 10,000 | $68.39 | 226,151 |
| Sep 2, 2025 | Brian G. Andrewsofficer: EVP, CFO & Treasurer | Purchase | 1,525 | $65.68 | 22,191 |
| Sep 2, 2025 | Daniel G. McBrideofficer: EVP & Chief Operating Officer | Purchase | 3,000 | $65.04 | 63,120 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Sen. Alan Armstrong | Purchase | $1,001 – $15,000 | Joint | Mar 27, 2026 | Jul 21, 2026 ↗ |
| Rep. Ro Khanna · CA17 | Purchase | $1,001 – $15,000 | Jun 22, 2026 | Jul 8, 2026 ↗ | |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jun 5, 2026 | Jul 3, 2026 ↗ | |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | May 29, 2026 | Jun 9, 2026 ↗ |